Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

NCT04317599 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT04317599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04317599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
Lead sponsor
Pierre Fabre Medicament
Phase
Observational
Overall status
Completed
Start date
April 12, 2020
Completion date
May 12, 2021
Enrollment
274 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

braf v600e mutation positive, metastatic colorectal cancer